Xtalks Announces its Life Science Webinar Calendar for January 2026
Upcoming free, educational webinars from Xtalks will feature topics on clinical trials, drug discovery & development, medical device and pharma manufacturing & supply chain.
Visit www.xtalks.com to see our upcoming webinars:
CLINICAL TRIALS
DRUG DISCOVERY & DEVELOPMENT
MEDICAL DEVICE
PHARMA MANUFACTURING & SUPPLY CHAIN
ABOUT XTALKS
Xtalks — The Life Science Community™ empowers professionals across pharma, biotech, medtech, healthcare and research with the trusted knowledge and collaborative insights that move the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks delivers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities and more designed to support informed decision-making in a fast-evolving sector.
Every year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives and industry thought leadership. Join our life science community to stay informed, connected and ready for what's next.
To learn more about Xtalks, visit www.xtalks.com
For information about working with Xtalks to host your webinar, visit https://xtalks.com/partner-with-us/
Contact:
Tel: +1 (416) 977-6555 x371
Email: [email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/xtalks-announces-its-life-science-webinar-calendar-for-january-2026-302654560.html
SOURCE Xtalks
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Early Bird Tickets Now on Sale | ICOMIA & Sinoexpo Unveil 2027 ICOMIA World Marinas Conference (Shanghai) Preliminary Programme
- Elauwit Connection, Inc. Delivers Largest Quarter-Over-Quarter and Year-Over-Year Increase in Contracted Units in Company History with 16% Sequential and 33% Annual Growth
- VNET Announces Strategic Cooperation with CATL
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share